Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia

Recent interest in mushrooms and their components as potential therapies for mental health, along with recent government and health authority approvals, has necessitated a more comprehensive understanding of their effects on the cellular microenvironment of the brain. Amanita muscaria has been inges...

Full description

Bibliographic Details
Main Authors: Ashley Wagner, Marcus Pehar, Zhimin Yan, Marianna Kulka
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-04-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1102465/full
_version_ 1797848024093818880
author Ashley Wagner
Marcus Pehar
Marcus Pehar
Zhimin Yan
Marianna Kulka
Marianna Kulka
author_facet Ashley Wagner
Marcus Pehar
Marcus Pehar
Zhimin Yan
Marianna Kulka
Marianna Kulka
author_sort Ashley Wagner
collection DOAJ
description Recent interest in mushrooms and their components as potential therapies for mental health, along with recent government and health authority approvals, has necessitated a more comprehensive understanding of their effects on the cellular microenvironment of the brain. Amanita muscaria has been ingested as a treatment for a variety of ailments for centuries, most notably those affecting the central nervous system and conditions associated with neuroinflammation. However, the effects of these extracts on neuroinflammatory cells, such as microglia, are unknown. The effect of commercially-sourced A. muscaria extract (AME-1) on human microglial cell line (HMC3) expression of surface receptors such as CD86, CXCR4, CD45, CD125 and TLR4 was determined by flow cytometry. AME-1 upregulated expression of all of these receptors. The effect of AME-1 on HMC3 production of IL-8 and IL-6 was determined and compared to tumor necrosis factor (TNF), polyinosinic-polycytidylic acid [poly(I:C)], substance P and lipopolysaccharide (LPS), all known activators of HMC-3 and primary microglia. HMC3 produced both IL-8 and IL-6 when activated with LPS, TNF and poly(I:C) but not when they were activated with substance P. Although AME-1 at higher concentrations increased IL-8 production of HMC3 on its own, AME-1 notably potentiated HMC3 production of IL-8 in response to poly(I:C). AME-1 altered expression of toll-like receptor 3 (TLR3) mRNA but not surface protein by HMC3. AME-1 also did not significantly alter expression of retinoic acid-inducible gene I (RIG-I) or melanoma differentiation-associated protein 5 (MDA5), both cytosolic sensors of dsRNA. Metabolomics analysis showed that AME-1 contained several metabolites, including the autophagy inducer, trehalose. Like AME-1, trehalose also potentiated HMC3 poly(I:C) mediated production of IL-8. This study suggests that A. muscaria extracts can modify HMC3 inflammatory responses, possibly due to their trehalose content.
first_indexed 2024-04-09T18:21:51Z
format Article
id doaj.art-2c94f757280646ffb419de3459bf9a35
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-09T18:21:51Z
publishDate 2023-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-2c94f757280646ffb419de3459bf9a352023-04-12T05:54:32ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-04-011410.3389/fphar.2023.11024651102465Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microgliaAshley Wagner0Marcus Pehar1Marcus Pehar2Zhimin Yan3Marianna Kulka4Marianna Kulka5Nanotechnology Research Centre, National Research Council Canada, Edmonton, AB, CanadaNanotechnology Research Centre, National Research Council Canada, Edmonton, AB, CanadaNeuroscience and Mental Health Institute, University of Alberta, Edmonton, AB, CanadaNanotechnology Research Centre, National Research Council Canada, Edmonton, AB, CanadaNanotechnology Research Centre, National Research Council Canada, Edmonton, AB, CanadaNeuroscience and Mental Health Institute, University of Alberta, Edmonton, AB, CanadaRecent interest in mushrooms and their components as potential therapies for mental health, along with recent government and health authority approvals, has necessitated a more comprehensive understanding of their effects on the cellular microenvironment of the brain. Amanita muscaria has been ingested as a treatment for a variety of ailments for centuries, most notably those affecting the central nervous system and conditions associated with neuroinflammation. However, the effects of these extracts on neuroinflammatory cells, such as microglia, are unknown. The effect of commercially-sourced A. muscaria extract (AME-1) on human microglial cell line (HMC3) expression of surface receptors such as CD86, CXCR4, CD45, CD125 and TLR4 was determined by flow cytometry. AME-1 upregulated expression of all of these receptors. The effect of AME-1 on HMC3 production of IL-8 and IL-6 was determined and compared to tumor necrosis factor (TNF), polyinosinic-polycytidylic acid [poly(I:C)], substance P and lipopolysaccharide (LPS), all known activators of HMC-3 and primary microglia. HMC3 produced both IL-8 and IL-6 when activated with LPS, TNF and poly(I:C) but not when they were activated with substance P. Although AME-1 at higher concentrations increased IL-8 production of HMC3 on its own, AME-1 notably potentiated HMC3 production of IL-8 in response to poly(I:C). AME-1 altered expression of toll-like receptor 3 (TLR3) mRNA but not surface protein by HMC3. AME-1 also did not significantly alter expression of retinoic acid-inducible gene I (RIG-I) or melanoma differentiation-associated protein 5 (MDA5), both cytosolic sensors of dsRNA. Metabolomics analysis showed that AME-1 contained several metabolites, including the autophagy inducer, trehalose. Like AME-1, trehalose also potentiated HMC3 poly(I:C) mediated production of IL-8. This study suggests that A. muscaria extracts can modify HMC3 inflammatory responses, possibly due to their trehalose content.https://www.frontiersin.org/articles/10.3389/fphar.2023.1102465/fullmicrogliainflammationtoll-like receptortrehaloseHMC3HMC3 cells
spellingShingle Ashley Wagner
Marcus Pehar
Marcus Pehar
Zhimin Yan
Marianna Kulka
Marianna Kulka
Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia
Frontiers in Pharmacology
microglia
inflammation
toll-like receptor
trehalose
HMC3
HMC3 cells
title Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia
title_full Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia
title_fullStr Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia
title_full_unstemmed Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia
title_short Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia
title_sort amanita muscaria extract potentiates production of proinflammatory cytokines by dsrna activated human microglia
topic microglia
inflammation
toll-like receptor
trehalose
HMC3
HMC3 cells
url https://www.frontiersin.org/articles/10.3389/fphar.2023.1102465/full
work_keys_str_mv AT ashleywagner amanitamuscariaextractpotentiatesproductionofproinflammatorycytokinesbydsrnaactivatedhumanmicroglia
AT marcuspehar amanitamuscariaextractpotentiatesproductionofproinflammatorycytokinesbydsrnaactivatedhumanmicroglia
AT marcuspehar amanitamuscariaextractpotentiatesproductionofproinflammatorycytokinesbydsrnaactivatedhumanmicroglia
AT zhiminyan amanitamuscariaextractpotentiatesproductionofproinflammatorycytokinesbydsrnaactivatedhumanmicroglia
AT mariannakulka amanitamuscariaextractpotentiatesproductionofproinflammatorycytokinesbydsrnaactivatedhumanmicroglia
AT mariannakulka amanitamuscariaextractpotentiatesproductionofproinflammatorycytokinesbydsrnaactivatedhumanmicroglia